Berkshire Hathaway Inc. (BRK.B) is a multinational conglomerate holding company headquartered in Omaha, Nebraska. The company, valued at a market cap of $1.1 trillion, is widely known for its disciplined investment philosophy, long-term value orientation, and decentralized management structure.

Companies worth $200 billion or more are generally described as “mega-cap stocks,” and BRK.B definitely fits that description, with its market cap exceeding this threshold, reflecting its substantial size, influence, and dominance in the insurance-diversified industry. The company is uniquely strong due to its exceptional leadership under Warren Buffett, a highly diversified portfolio of wholly-owned businesses, and a world-class equity investment portfolio.

Berkshire slipped 7.2% from its 52-week high of $542.07, achieved on May 2. Over the past three months, BRK.B stock declined 2.1%, trailing the broader Nasdaq Composite’s ($NASX) 1.4% rise over the same time frame.

However, in the longer term, shares of Berkshire rose 11% on a YTD basis and climbed 24.6% over the past 52 weeks, outperforming $NASX’s YTD dip of 1.1% and 12.2% returns over the last year.

Berkshire has been trading above its 200-day moving average for the past year. However, it has been trading below its 50-day moving average since mid-May.

On May 3, Berkshire stock dropped over 5% after the company released its Q1 results. Revenue came in at $89.72 billion, slightly lower than the $89.86 billion reported in the same quarter last year and below the Street’s estimate of $92.2 billion. Its EPS fell to $4.47 from $5.19 a year ago, missing analysts’ expectations by 7.1%.

In the competitive arena of finance, JPMorgan Chase & Co. (JPM) has taken the lead over Berkshire, showing resilience with a 32.1% uptick over the past 52 weeks. However, JPM lagged behind the stock with a 9.9% gain on a YTD basis.

Wall Street analysts are moderately bullish on BRK.B’s prospects. The stock has a consensus “Moderate Buy” rating from the six analysts covering it, and the mean price target of $541.50 suggests a potential upside of 7.6% from current price levels